Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
0.9500
-0.1100 (-10.38%)
Mar 31, 2025, 2:26 PM EDT - Market open
Alzamend Neuro Stock Forecast
ALZN's stock price has decreased by -89.61% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Alzamend Neuro stock has a target of 20, which predicts an increase of 2,005.26% from the current stock price of 0.95.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Alzamend Neuro is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $32 → $20 | Strong Buy | Maintains | $32 → $20 | +2,005.26% | Mar 17, 2025 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $35 → $32 | Strong Buy | Maintains | $35 → $32 | +3,268.42% | Dec 16, 2024 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $50 → $35 | Strong Buy | Maintains | $50 → $35 | +3,584.21% | Nov 11, 2024 |
Maxim Group | Maxim Group | Strong Buy Initiates $225 | Strong Buy | Initiates | $225 | +23,584.21% | Apr 12, 2023 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $1,200 | Strong Buy | Initiates | $1,200 | +126,215.79% | Oct 1, 2021 |
Financial Forecast
Revenue This Year
138.75M
from 32.83M
Increased by 322.64%
Revenue Next Year
n/a
from 138.75M
EPS This Year
-1.64
from -14.70
EPS Next Year
-1.24
from -1.64
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | n/a | n/a | n/a | |||
Avg | n/a | n/a | n/a | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | -1.39 | -0.79 | -0.85 | |||
Avg | -1.64 | -1.24 | -0.83 | |||
Low | -1.86 | -1.66 | -0.79 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.